With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

After disappointing trial results for cancer treatments, Mural Oncology announced Wednesday it is cutting 90% of its workforce.

While President Trump and Elon Musk have cut spending on research and grants that fueled the life sciences and climate tech ...

A Cambridge biotech has taken over development of a Roche rare disease drug, Cue Biopharma signed a deal with Boehringer ...

A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

“Lots of companies are limping along,” said Mani Foroohar, senior research analyst at Boston health care investment bank Leerink Partners. Foroohar, a top biotech analyst, has slapped an ...

J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as multiple myeloma asset inobrodib progresses to late-stage clinical development.

NORTHAMPTON, MA / ACCESS Newswire / April 4, 2025 / In the biotechnology sector, innovation extends beyond medical discoveries to include approaches for managing environmental impact. For example ...

Since its peak in 2021, VC funding for women-led ventures has struggled to remain consistent. However, deal value rebounded in 2024, and the deal count continued on its downward trend from 2021.

You can meet a lot of Worcester-educated entrepreneurs, and visit a lot of Worcester-hatched biotech companies — in Boston. Brad McNamara is among them. I first connected with McNamara when he ...